MaxCyte, Inc. (MXCT) Tops Q1 EPS by 1c

MaxCyte, Inc. (NASDAQ: MXCT) reported Q1 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $10.4 million versus the consensus estimate of $9.05 million.

For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.

You May Also Be Interested In

• JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue
• Mizuho Reiterates Outperform Rating on Occidental Petroleum (OXY)
• Morgan Stanley (MS) call put ratio 1 call to 1.2 puts into quarter results